A B S T R A C T We have tested the idea that the circulating plasma insulin level plays an important role in the long-term regulation, or maintenance, of the cellular glucose transport system, distinct from insulin's ability to acutely accelerate glucose transport. To study this hypothesis, groups of rats were made either hyperinsulinemic or hypoinsulinemic by daily insulin injections, or streptozotocin treatment, respectively. Different levels of hypoinsulinemia were produced by using different doses of streptozotocin (40 and 55 mg/kg). The mean (+SE) 9 a.m. plasma insulin level for each experimental group was: hyperinsulinemic animals, 65+5 ,uU/ml; controls, 32+3 AU/ml; low dose streptozotocin group, 18+3 ,uU/ml; and high dose streptozotocin group 5+2 ,uU/ml. Isolated adipocytes were prepared from each animal and glucose transport was assessed by measuring the initial rates of uptake of the nonmetabolyzable hexose 2-deoxy glucose. The Vmax and Km values for adipocyte glucose transport were calculated from the 2-deoxy glucose uptake data. The hypoinsulinemic rats. Furthermore, when the individual data were analyzed, highly significant correlation coefficients were found between the height ofthe plasma insulin level and both the basal (r = 0.82, P < 0.001) and insulin-stimulated (r = 0.93, P < 0.001) Vmax values. The apparent Km for 2-deoxy glucose uptake was the same under all conditions.
INTRODUCTION
Insulin stimulates the carrier-mediated transport of glucose in a number of cell types, and this process is an important rate controlling step in glucose metabolism (1) . Although the precise mechanism of insulin's ability to accelerate glucose transport is not known, it has been demonstrated that a very brief exposure to insulin promotes glucose transport by increasing the Vmax of the transport process without changing the Km (2) (3) (4) . Because of the short exposure time necessary for this effect, it is thought that insulin activates existing transport units (5) and does not promote the synthesis of new carrier proteins. Thus, this process provides a means whereby insulin can acutely regulate glucose metabolism. On the other hand, it seems possible that insulin may also play a role in the long-term regulation, or maintenance, of the glucose transport system. For example, we have found that fasting leads to a pro-gressive decrease in the Vmax of adipocyte glucose transport and that the decline in maximal transport capacity correlated quite well with the fasting-induced fall in plasma insulin levels (6) . Furthermore, Kipnis et al. (7, 8) and Morgan et al. (9, 10) have demonstrated that alloxan-induced diabetes leads to decreased glucose transport in the rat diaphragm (7, 8) and heart muscle (9, 10) . Thus, there is some precedent to suspect that hypoinsulinemic states may be associated with depressed glucose transport activity. Additionally, Smith (11) has reported that when adipocytes are cultured in the presence of insulin for 1 wk, the cells subsequently have an increased capacity for glucose uptake and metabolism compared to control cells cultured in the absence of insulin. Thus, it is our hypothesis that the level of insulin to which cells are chronically exposed plays an important role in the long-term regulation of the capacity of the glucose transport system. If one assumes that the transport Vmax is some function of' the number of glucose transport units per cell (5) , then our hypothesis would be that the height of the plasma insulin level regulates the number of' available carrier proteins in the plasma membranes of target cells. To test this idea we have chronically modified the in vivo plasma insulin level in rats by various treatments and have simultaneously assessed the Vmax of adipocyte glucose transport. The results demonstrate, that under all circumstances there is an excellent correlation between the height ofthe in vivo plasma insulin level and the in vitro adipocyte transport Vmax. Hyperinsulinemic rats. The experimentally hyperinsulinemic rats were prepared by dividing 110-120:g rats into two groups. One group was injected subcutaneously with Neutral protamine Hagedorn insulin every 12 h (9 a.m. and 9 p.m.), in gradually increasing dosages (from 0.5 U to 6 U/day) for 14 days. Two-thirds of' the daily amount of insulin was given at 9 p.m., and one-third at 9 a.m. An identical volume of' Neutral protamine Hagedorn insulin diluting solution was injected into control animals. To prevent hypoglycemia, all animals had f'ree access to sugar cubes and 5% glucose drinking water, in addition to normal rat chow. Both groups were f'ed ad lib until the morning of' all studies. On day 15, rats were sacrificed and blood was collected for the determination of' plasma glucose and insulin.
METHODS
Insulin-deficient rats. Insulin-deficient diabetes was induced by injecting rats (via tail vein) with streptozotocin (STZ)l prepared in citrate buffer, pH 4.0. Animals weighing 160-170 g were divided into three groups. The first, or high dose group, was injected with 55 mg/kg STZ; the second, or low dose group, was injected with 40 mg/kg STZ; and the third, or control group, was given an identical volume of' citrate buffer. 7 days after the injection, animals were sacrificed and blood was collected for determination of plasma glucose and insulin. All groups were f'ed ad lib until the morning of all studies. Food intake and body weight were measured daily. Because the results from the control groups for the hyperinsulinemic rats and the STZ-treated groups were similar, the data f'rom the two control groups have been combined.
Hyperglycemic, Noninsulin-deficient rats. To produce hyperglycemia in the absence of' hypoinsulinemia an additional series of' rats, weighing 160 g initially, were treated with 3-ml injections of a 30% glucose solution intraperitoneally at 8 a.m., 3 p.m., and 9 p.m. f'or 7 days. Tail vein blood was obtained for determination of' plasma glucose levels before each injection.
Preparation of isolated adipocytes. All studies were begun at 9 a.m. Animals were stunned by a blow to the head, decapitated, and epididymal fat pads were removed. Isolated fat cells were prepared by shaking at 37°C for 60 min in Krebs-Ringer bicarbonate buffer containing collagenase (3 mg/ml) and bovine serum albumin (40 mg/ml) according to the method of Rodbell (12) . Cells were filtered through 250 ,uM nylon mesh, centrifuged at 400 rpm for 4 min, and washed twice in buffer (13) . Adipocyte counts were perf'ormed according to a modification of' method III of Hirsch and Gallian (14) , in which the cells were fixed in 2% osmium tetroxide in 0.05 M collidine buffer (made isotonic with saline) for 24 h at 37°C and then taken up in a known volume of 0.154 M NaCl for counting with a Coulter counter model ZB (Coulter Electronics, Inc., Hialeah, Fla.). Adipocyte size was determined with a calibrated microscope by the method of Di Girolamo et al. (15) .
Glucose transport studies. Transport studies were perf'ormed by measuring the initial uptake rates of 2-deoxy glucose. The details and validation of this method have been described (4) (5) (6) 16) . Briefly, isolated adipocytes were incubated with 2-deoxy-D-[1-14C]glucose (2 mCi/mM sp act) at various concentrations in Krebs-Ringer bicarbonate buffer, pH 7.4, containing bovine serum albumin (10 mg/ml) at 24°C. The assay measures the total uptake of the radiolabeled 2-deoxy glucose and is based on the principle that although 2-deoxy glucose is transported and phosphorylated by the same process as D-glucose it cannot be further metabolized (17 
RESULTS
Experimental animals. Some characteristics of the experimental animals are presented in Table I . As can be seen, daily weight gain and food consumption were identical in control, insulin-, and glucosetreated animals. Daily weight gain of the high dose (55 mg/kg) STZ-treated animals was markedly less than control, despite normal food intake, whereas the low dose group (40 mg/kg) gained weight at a near normal rate. Thus, in this latter group significant negative caloric balance was absent despite moderate insulin deficiency. Fat cell size was increased in the insulintreated group, and decreased in the STZ-treated animals. Plasma insulin levels were measured at 9 a.m.
(-12 h after the last insulin injection in the insulintreated animals), and were significantly increased in the insulin-treated animals and significantly decreased in both STZ-treated groups.
Experimentally hyperinsulinemic rats. Fig. 1 summarizes the glucose transport studies performed on isolated adipocytes from the experimentally hyperinsulinemic and control animals. 2-deoxy glucose uptake was studied over a wide range of hexose concentrations in the absence and presence of a maximally effective insulin level (25 ng/ml) in the buffer. In the presence of insulin, adipocytes from the experimentally hyperinsulinemic animals took up markedly more 2-deoxy glucose at all hexose concentrations. Although less striking, basal rates of 2-deoxy glucose uptake were also significantly higher for the hyperinsulinemic group. The shape of the curves in Fig. 1 Table II. actual hypoglycemia was not a feature of the hyperinsulinemic animals, the plasma glucose levels were lower (Table I) closely associated with the increase in Vmax. STZ-treated rats. The ability of adipocytes from STZ-, glucose-treated, and control rats to take up 2-deoxy glucose is shown in Fig. 3 . 2-deoxy glucose uiptake is clearly decreased in both STZ-treated diabetic groups, and this decrease is greater in the more insulin-deficient diabetic animals who received the higher dose (55 mg/kg) of STZ. When the data from Fig. 3 were analyzed on a Lineweaver-Burk plot (Fig. 4) , the Vmax values were lower in the STZtreated diabetic animals and the magnitude of this decrease in Vmax was greater in the more hypoinsulinemic group. On the other hand, the Km value was unchanged in any of the experimental conditions. It should be noted that in the low dose STZ group, the slope of the nonsaturable component is increased, at least in the basal state, and the reason for this is unexplained. Because this leads to a higher proportion of total uptake accounted for by diffusion, this curve (Fig. 3A , low dose STZ) is less suitable than the other uptake curves for kinetic analysis.
An additional group of rats was given glucose injections designed to approximate the degree of hyperglycemia seen in the diabetic rats who received the low dose of STZ. These animals were given 3 ml of a 30% glucose solution i.p. at 8 a.m., 3 p.m., and 9 p.m. Mean plasma glucose values just before each injection were 178, 210, and 210 mg/100 ml, respectively, and these values represent the minimum level of hyperglycemia throughout the day since they were obtained when the glycemic effect of the preceeding glucose injection was least. Although these rats were Validity of 2-deoxy glucose uptake as a measure of glucose transport. Because 2-deoxy glucose can be phosphorylated as well as transported, it is important to determine that hexokinase activity does not influence the initial rates of 2-deoxy glucose uptake. Theoretically, uptake represents the balance between sugar influx and efflux, and to assess initial transport rates it is essential to measure influx under circumstances where efflux is minimal or nonexistent. If hexokinase activity were rate determining for 2-deoxy glucose uptake, at any time during the experiment, then there would be significant accumulation of intracellular unphosphorylated 2-deoxy glucose. Because phosphorylated sugars are "trapped" within the cell and only the unphosphorylated hexose can efflux, if hexokinase activity were limiting, net uptake of 2-deoxy glucose would not be a linear function of time. However, time-course studies have shown that 2-deoxy glucose uptake is strictly linear with time under all the experimental conditions employed (data not shown, also see ref. 5). Thus, this demonstrates that true unidirectional flux is being measured rather than net flux complicated by significant sugar efflux.
This contention can be tested more directly by measuring the intracellular concentrations of 2-deoxy glucose, and 2-deoxy glucose-phosphate at the time net uptake is assessed. These data are provided in Table  III . As can be seen intracellular levels of free 2-deoxy glucose are absent or minimal compared to the extracellular levels in normal and experimental animals. Therefore, because efflux is concentration dependent (3), 2-deoxy glucose efflux must be minimal relative to influx. From these and other (5) studies, we believe that initial rates of 2-deoxy glucose uptake provide a valid and quantitative measure of adipocyte glucose transport.
Relationship between Vmax and plasma insulin levels. As shown in Table II , an increased Vmax was found in adipocytes from insulin-treated hyperinsulinemic rats, and a decreased Vmax was seen in adipocytes from hypoinsulinemic rats. This is consistent with the idea that the ambient plasma insulin level is an important factor in the long-term regulation of the cell's overall capacity for glucose transport. This idea is further supported when the individual data are analyzed. Thus, when the Vmax values are plotted against the plasma insulin levels of the individual animals from each study group (Fig. 5) , an excellent correlation was found between the height of the plasma insulin level and the Vmax of glucose transport in both the basal (r = 0.82, P < 0.001) and insulin-stimulated state (r = 0.93, P < 0.001).
DISCUSSION
It is well recognized that insulin can acutely promote carrier-mediated glucose transport in insulin sensitive tissues by increasing the Vmax of the transport process (1-4) . Recently, we have provided evidence indicating that this acute stimulatory effect is mediated by an increase in the number of functioning carriers (5). Because full stimulation of transport is seen within a few (6) . Furthermore, Smith (11) has shown that when adipocytes are cultured in the presence of a high glucose level (5.6 mM) their subseqluent ability to metabolize glucose is greater than when they are cultured with a low glucose concentration (1 mM). One might also argue that the decreased transport Vmax of the high dose STZ-treated animals is a result of the weight loss and catabolic state of these animals rather than the hypoinsulinemia. However, this also seems unlikely because the low dose STZ-treated animals gained weight at a near normal rate (Table I) Vmax values paralleled changes in plasma insulin levels in several entirely different animal models, we believe the data are most consistent with the concept that plasma insulin is a long-term regulator of glucose transport capacity. This conclusion is further strengthened when the individual data were examined. Thus, when the results fiom all the groups were combined, a highly significant positive correlation was found between each animal's plasma insulin level and Vmax value in both the basal and insulin-stimulated state.
These conclusions are not dependent on the method of data expression. For example, one could argue that because glucose transport is a membrane phenomenon, transport data should be normalized to plasma membrane surface area rather than to cell number. Although the data presented cannot resolve which method of normalization is most valid, as seen in Table II , despite the f'act that adipocyte size varied among the different experimental groups, expressing the data on the basis of unit plasma meml)rane surface area did not change any of the relationships between plasma insulin levels and Vmax values.
Data from other animal studies are also supportive of this relationship. For example, in an extensive series of papers published a number of years ago, Kipnis et al. (7, 8) and Morgan et al. (9, 10) , clearly demonstrated that alloxan-induced diabetes led to decreased glucose transport activity of rat muscle. Although plasma insulin levels were not measured in these earlier studies (7) (8) (9) (10) , and although the decrease in transport was not directly related to hypoinsulinemia or to the severity of the diabetes, these reports are clearly consistent with the current results. Additionally, Goodman et al. (26) have found decreased glucose uptake by perfused hindlimbs of insulindeficient streptozotocin-treated diabetic rats. Furthermore, as rats are fasted for 24-72 h, plasma insulin levels progressively decline, and this is associated with a stepwise fall in the Vmax of adipocyte glucose transport (6) . Clearly, all of these studies are consistent with the above described relationship between plasma insulin levels and adipocyte glucose transport.
Lastly, in addition to indicating a new mechanism whereby insulin can serve as a more chronic regulator of glucose homeostasis, the present results may also relate to the insulin resistance of certain diabetic states. For example, severely insulin-deficient, ketosis prone, animals and man have been shown to be insulin resistant (27) (28) (29) 
